Get the Stockscreener App
22.03
1.39%
-0.31
Pre-market:
22.23
0.20
+0.91%
Arrowhead Pharmaceuticals Inc stock is traded at $22.03, with a volume of 2.27M.
It is down -1.39% in the last 24 hours and up +38.38% over the past month.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
See More
Previous Close:
$22.34
Open:
$22.43
24h Volume:
2.27M
Relative Volume:
1.15
Market Cap:
$3.05B
Revenue:
$181.74M
Net Income/Loss:
$-143.97M
P/E Ratio:
-15.85
EPS:
-1.39
Net Cash Flow:
$9.60M
1W Performance:
+3.28%
1M Performance:
+38.38%
6M Performance:
+16.31%
1Y Performance:
-8.51%
1-Day Range:
$21.61
$22.55
1-Week Range:
$20.45
$22.75
52-Week Range:
$9.57
$27.34
Arrowhead Pharmaceuticals Inc Stock (ARWR) Company Profile
Name
Arrowhead Pharmaceuticals Inc
Sector
Industry
Phone
626-696-4702
Address
177 E COLORADO BLVD, PASADENA, CA
Compare ARWR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARWR
Arrowhead Pharmaceuticals Inc
|
22.03 | 3.09B | 181.74M | -143.97M | 9.60M | -1.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Arrowhead Pharmaceuticals Inc Stock (ARWR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-05-24 | Initiated | Goldman | Neutral |
| Dec-04-23 | Initiated | BofA Securities | Buy |
| Sep-19-23 | Initiated | Citigroup | Neutral |
| Jul-21-23 | Initiated | TD Cowen | Outperform |
| May-12-23 | Downgrade | SVB Securities | Outperform → Market Perform |
| Apr-26-23 | Initiated | SMBC Nikko | Outperform |
| Apr-12-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Mar-21-23 | Initiated | Bernstein | Mkt Perform |
| Sep-09-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-11-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-19-22 | Resumed | Goldman | Buy |
| Aug-06-21 | Reiterated | Chardan Capital Markets | Buy |
| Jun-04-21 | Resumed | Robert W. Baird | Neutral |
| Feb-05-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-21-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-16-20 | Initiated | UBS | Buy |
| Nov-19-20 | Initiated | Citigroup | Buy |
| May-13-20 | Initiated | RBC Capital Mkts | Outperform |
| May-08-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-15-20 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Mar-24-20 | Upgrade | SVB Leerink | Underperform → Mkt Perform |
| Mar-17-20 | Initiated | Goldman | Neutral |
| Jan-21-20 | Initiated | SVB Leerink | Underperform |
| Dec-13-19 | Initiated | Oppenheimer | Perform |
| Nov-29-19 | Reiterated | Chardan Capital Markets | Buy |
| Nov-27-19 | Reiterated | B. Riley FBR | Buy |
| Nov-25-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-24-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-22-19 | Reiterated | Chardan Capital Markets | Buy |
| Oct-03-19 | Initiated | Robert W. Baird | Outperform |
| Sep-07-18 | Upgrade | B. Riley FBR | Neutral → Buy |
| Sep-06-18 | Reiterated | Chardan Capital Markets | Buy |
| Aug-08-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Jul-02-18 | Reiterated | Chardan Capital Markets | Buy |
View All
Arrowhead Pharmaceuticals Inc Stock (ARWR) Latest News
Arrowhead Pharmaceuticals Inc. stock daily chart insightsJuly 2025 Intraday Action & Free Fast Gain Swing Trade Alerts - Newser
Will Arrowhead Pharmaceuticals Inc. price bounce be sustainablePortfolio Gains Report & Step-by-Step Trade Execution Guides - Newser
Long term hold vs stop loss in Arrowhead Pharmaceuticals Inc.Weekly Trading Summary & Daily Growth Stock Investment Tips - Newser
Bollinger Bands Show Potential Breakout in Arrowhead Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr
Arrowhead Pharmaceuticals Inc. stock momentum explained2025 Fundamental Recap & Safe Swing Trade Setup Alerts - Newser
Volume spikes in Arrowhead Pharmaceuticals Inc. stock – what they meanWeekly Investment Summary & Expert Approved Trade Ideas - Newser
Institutional Ownership: A Key Indicator for Arrowhead Pharmaceuticals' Stock Performance - AInvest
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional owners may be pleased with recent gains after 7.6% loss over the past year - Yahoo Finance
Can trapped investors hope for a rebound in Arrowhead Pharmaceuticals Inc.2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - Newser
Is Arrowhead Pharmaceuticals Inc. forming a bottoming base2025 Investor Takeaways & Capital Efficiency Focused Strategies - Newser
Identifying reversal signals in Arrowhead Pharmaceuticals Inc.Weekly Profit Analysis & Technical Buy Zone Confirmations - Newser
Is Arrowhead Pharmaceuticals Inc. stock entering bullish territoryInsider Buying & Reliable Momentum Entry Alerts - Newser
Order flow analysis tools used on Arrowhead Pharmaceuticals Inc.Trade Volume Summary & Weekly High Momentum Picks - Newser
How to use Fibonacci retracement on Arrowhead Pharmaceuticals Inc.2025 Stock Rankings & AI Forecasted Stock Moves - Newser
Can a trend reversal in Arrowhead Pharmaceuticals Inc. lead to recoveryEarnings Growth Summary & Free Community Supported Trade Ideas - Newser
Arrowhead Pharmaceuticals Inc. stock volume spike explainedTrade Entry Report & Weekly Setup with ROI Potential - Newser
Smart tools for monitoring Arrowhead Pharmaceuticals Inc.’s price actionVolume Spike & Daily Momentum Trading Reports - Newser
Is Arrowhead Pharmaceuticals Inc. forming a double bottom getLinesFromResByArray error: size == 0 - 클래시안
Published on: 2025-08-31 13:51:49 - Newser
Using data models to predict Arrowhead Pharmaceuticals Inc. stock movementOil Prices & High Yield Stock Recommendations - Newser
Why Arrowhead Pharmaceuticals Inc. stock attracts strong analyst attentionPortfolio Update Summary & Advanced Swing Trade Entry Plans - Newser
Arrowhead Pharmaceuticals Inc. stock outlook for YEARInsider Selling & Daily Market Momentum Tracking - Newser
How to forecast Arrowhead Pharmaceuticals Inc. trends using time seriesAnalyst Upgrade & Weekly High Conviction Ideas - Newser
Analyzing net buyer seller activity in Arrowhead Pharmaceuticals Inc.Sell Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Tick level data insight on Arrowhead Pharmaceuticals Inc. volatilityLong Setup & Risk Adjusted Swing Trade Ideas - Newser
What’s next for Arrowhead Pharmaceuticals Inc. stock price2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Historical volatility pattern of Arrowhead Pharmaceuticals Inc. visualized2025 Market Sentiment & Safe Entry Zone Tips - Newser
Detecting price anomalies in Arrowhead Pharmaceuticals Inc. with AIAnalyst Upgrade & Advanced Swing Trade Entry Plans - Newser
Arrowhead Pharmaceuticals Inc Stock (ARWR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):